Short Report

You have full text access to this OnlineOpen article

Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects

  1. Peter McColgan,
  2. Pankaj Sharma*

Article first published online: 19 MAR 2009

DOI: 10.1002/ijc.24441

Issue

International Journal of Cancer

International Journal of Cancer

Volume 125, Issue 6, pages 1473–1478, 15 September 2009

Additional Information

How to Cite

McColgan, P. and Sharma, P. (2009), Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int. J. Cancer, 125: 1473–1478. doi: 10.1002/ijc.24441

Author Information

  1. Imperial College Cerebrovascular Research Unit (ICCRU), Imperial College London, Hammersmith Hospitals, London, United Kingdom

*Imperial College Cerebrovascular Research Unit (ICCRU), Imperial College London, Hammersmith Hospitals, Fulham Palace Rd, London W6 8RF, United Kingdom

Publication History

  1. Issue published online: 14 JUL 2009
  2. Article first published online: 19 MAR 2009
  3. Manuscript Accepted: 3 MAR 2009
  4. Manuscript Received: 11 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (293K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patricia González-Arriaga, Teresa Pascual, Arturo García-Alvarez, Ana Fernández-Somoano, M Felicitas López-Cima, Adonina Tardón, Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival, BMC Cancer, 2012, 12, 1, 121

    CrossRef

  2. 2
    Bingxue Shang, Zhifei Cao, Quansheng Zhou, Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives, Frontiers of Medicine, 2012, 6, 1, 67

    CrossRef

  3. 3
    Jing Zhou, Constance Brinckerhoff, Susan Lubert, Kui Yang, Jasmine Saini, Jeffrey Hooke, Richard Mural, Craig Shriver, Stella Somiari, Analysis of Matrix Metalloproteinase-1 Gene Polymorphisms and Expression in Benign and Malignant Breast Tumors, Cancer Investigation, 2011, 29, 9, 599

    CrossRef

  4. 4
    Chandramu Chetty, Jasti S Rao, Sajani S Lakka, Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma, Pharmacogenomics, 2011, 12, 4, 535

    CrossRef

  5. 5
    Le-yao Zhang, Ke-wei Ren, Meta-Analysis of MMP2 –1306T Allele as a Protective Factor in Digestive Cancer, Archives of Medical Research, 2011, 42, 3, 239

    CrossRef

  6. 6
    Jin Huang, Jie Zhang, Yuliang Zhao, Banghua Liao, Jiaming Liu, Ling Li, Mingheng Liao, Lanlan Wang, The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis, Molecular Biology Reports, 2011, 38, 7, 4565

    CrossRef

  7. 7
    Ping Zhou, Liang-Feng Du, Guo-Qiang Lv, Xian-Ming Yu, Yuan-Long Gu, Jian-Ping Li, Chun Zhang, Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis, Breast Cancer Research and Treatment, 2010, 127, 3, 813

    CrossRef

  8. 8
    Ajay Kumar Chaudhary, Shruti Pandya, Ravi Mehrotra, Alok C. Bharti, Sachin Jain, Mamta Singh, Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population, Biomarkers, 2010, 15, 8, 684

    CrossRef

  9. 9
    Florian M. Kovar, Christiane Thallinger, Claudia L. Marsik, Thomas Perkmann, Harald Puhalla, Helmuth Haslacher, Fritz Wrba, Oswald F. Wagner, Thomas Gruenberger, Georg Endler, The EGF 61A/G polymorphism – a predictive marker for recurrence of liver metastases from colorectal cancer, Wiener klinische Wochenschrift, 2009, 121, 19-20, 638

    CrossRef

View Full Article (HTML) Get PDF (293K)